MDS Virtual Congress 2021 » Parkinsonism, Atypical: PSP, CBD

A retrospective review of clinical and MRI/CT radiological correlation in progressive supranuclear palsy (PSP)

T. Wongwarawipat, G. Shepherd, A. Chatterjee (Reading, United Kingdom)

A retrospective review of clinical features of Progressive Supranuclear Palsy (PSP) in a movement disorders clinic

G. Shepherd, T. Wongwarawipat, A. Chatterjee (Reading, United Kingdom)

An evaluation of the application of clinical research criteria for corticobasal degeneration in a large clinico-pathological series

D. Lux, L. Wu, H. Ling, T. Warner, A. Lees, T. Revesz, Z. Jaunmuktane, J. Rohrer, H. Morris (London, United Kingdom)

Automated Midbrain-Pons Ratio using Artificial Intelligence Differentiates PSP from other Atypical Parkinsonian Disorders

M. Peres, G. Leroy, A. Gerhard, M. Hu, J. Klein, P. Leigh, A. Church, D. Burn, H. Morris, J. Rowe, T. Rittman (Cambridge, United Kingdom)

Backward Fall Protection Garment for patients of PSP and other Parkinsonian Syndromes.

H. Singh, D. Singhal, N. Sawal, A. Beri, S. Kumar, G. Hundal, A. Chawla (Chandigarh, India)

Benign Progressive Supranuclear Palsy: mild pathology associated with parkinsonism

B. Couto, I. Martinez-Balbuena, S. Lee, N. Visanji, A. Lang, G. Kovacs (Toronto, Canada)

Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort – the OxQUIP study.

M. Pereira, C. Antoniades (Oxford, United Kingdom)

Fatigue in patients with progressive supranuclear palsy

JH. Ahn, J. Song, I. Choi, DY. Lee, J. Youn, JW. Cho (Seoul, Republic of Korea)

Language impairment in Corticobasal Syndrome: from clinical phenotype to biomarkers

J. Parmera, M. Oliveira, A. Coutinho, I. de Almeida, C. Carneiro, A. Neto, R. Nitrini, C. Buchpiguel, E. Barbosa, S. Brucki (São Paulo, Brazil)

Neuroimaging associations to gait impairments in progressive supranuclear palsy

I. Sintini, K. Kaufman, S. Loushin, H. Botha, P. Martin, M. Senjem, R. Reid, C. Schwarz, C. Jack, V. Lowe, K. Josephs, J. Whitwell, F. Ali (Rochester, USA)

Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy

M. Brzezicki, C. Antoniades (Oxford, United Kingdom)

Plasma microRNA expression profiling in patients with progressive supranuclear palsy. A five-microRNA panel in plasma was identified as a potential biomarker for progressive supranuclear palsy

R. Yadav, P. Ramaswamy, P. Pal, R. Christopher (Bengaluru, India)

Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort

A. Neji, A. Nasri, I. Sghaier, S. Mrabet, M. Bendjebara, I. Kacem, R. Gouider (Tunis, Tunisia)

Quantitative downgaze palsy predicts the survival duration in patients with progressive supranuclear palsy

T. Xie, C. Yuen, W. Kang, M. Padmanaban, T. Han, J. Nichols (Chicago, USA)

Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders

P. Zhang, J. Chen, T. Cai, Y. Zhang (Guangzhou, China)

The loss of skeletal muscle mass in progressive supranuclear palsy

Y. Takamatsu, I. Aiba (Sapporo, Japan)

Unusual Progressive Supranuclear Palsy: a case report

L. Megherbi, H. Si Ahmed, S. Daoudi (Tizi Ouzou, Algeria)